On August 17, NEJM Resident 360 will move to a new platform. Please note that we are temporarily suspending new account creation from Thursday, August 11, at 12 PM ET, until the site is live on August 17. Existing members will be sent an email with instructions for accessing their account on the new platform.* We look forward to sharing a fresh new look, easier navigation, and improved organization.
*If you currently sign in using Facebook or Twitter, you may need to create a new account after August 17.
Veeraish “VC” Chauhan, MD, is a nephrologist practicing in Bradenton/Lakewood Ranch, Florida. After studying Environmental Health at the Harvard School of Public Health, Boston, he completed his Internal Medicine and Nephrology training at Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, PA. He spends his time between clinical practice, teaching medical students and residents, and research. His clinical interests lie in newer therapies to prevent kidney disease progression, and resistant hypertension management. He is big believer in the power of internet and social media in furthering “real-time” medical education. He believes that patients too need reliable tools to understand evidence-based medicine, in order to make informed choices. To that end, he writes a popular blog titled “Demystifying Kidney Disease for the Average Joe!”. He is a Fellow of the American Society of Nephrology (FASN), and the American College of Physicians (FACP). In his spare time, he loves to run, scuba dive, and play with his two kids.
Kassem is a transplant nephrologist at the Massachusetts General Hospital. He was a transplant fellow at the MGH after he completed his nephrology fellowship at the combined MGH/BWH. He completed his internal medicine residency at Yale New Haven.
Kassem is currently a Reviewer for the Nephrology Dialysis Transplantation journal and the Transplantation journal.
His current research projects include the "Effect of Dietary Salt on the Alloimmune Response" and the association between induction therapy and cancer.
Kassem has taught the second year Harvard Medical School students in Renal Pathophysiology for the last 2 years. He won the "Excellence in Tutorial Facilitation" and was a nominee for the "Donald O'Hara Faculty Prize for Excellence in Teaching."
Dr. Chon is an associate professor of medicine at the University of Missouri at Kansas City School of Medicine and serves as the Medical Director of the Renal Transplant Program at Saint Luke's Health System. He is an experienced transplant nephrologist and is board-certified in Internal Medicine and Nephrology. His research interests include ethics in transplantation, BK virus nephropathy, and vaccinations in transplant patients. He has served as Chairman for the American Society of Transplanation (AST) Trainee and Young Faculty Community of Practice.